Healthcare - Biotechnology - NASDAQ - US
$ 2.74
-5.19 %
$ 105 M
Market Cap
-2.8
P/E
CASH FLOW STATEMENT
-43.8 M
OPERATING CASH FLOW
49 M
INVESTING CASH FLOW
-30 K
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Leap Therapeutics, Inc.
| Net Income | -81.4 M |
| Depreciation & Amortization | 15 K |
| Capital Expenditures | 0 |
| Stock-Based Compensation | 5.13 M |
| Change in Working Capital | 2.51 M |
| Others | 30.5 M |
| Free Cash Flow | -43.8 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||
| Net Income | (81.4) | (54.6) | (40.6) | (27.5) | (32.9) | (23.1) | (29.7) | (25.6) | (21.1) | (25.5) | (18.3) | (7.8) |
| Depreciation & Amortization | 15 K | 16 K | 29 K | 34 K | 47 K | 49 K | 48 K | 25 K | 0.5 | 0.7 | 0.6 | 0.6 |
| Deferred Income Tax | 0 | 0.2 | 0.4 | (0.7) | 3 K | 20 K | (0.2) | 0 | 0.4 | (0.3) | 85 K | 93 K |
| Stock Based Compensation | 5.1 | 5.2 | 3.5 | 2.6 | 3.9 | 3.5 | 5.6 | 45 K | 1.7 | 1.7 | 2.6 | 0.2 |
| Other Operating Activities | 30.0 | 0.9 | 0.5 | 0.6 | 0.7 | (7.3) | (0.2) | 1.2 | 14 K | 4.5 | 4.5 | (1.0) |
| Change in Working Capital | 2.5 | (0.7) | 1.0 | (1.0) | 1.3 | 0.9 | 2.3 | (1.0) | (1.1) | 0.8 | 0.6 | 0.3 |
| Cash From Operations | (43.8) | (49.0) | (35.2) | (26.0) | (26.9) | (26.0) | (22.1) | (25.3) | (19.6) | (18.0) | (9.9) | (7.5) |
| INVESTING CASH FLOW | ||||||||||||
| Capital Expenditures | 0 | 0 | 0 | 0 | 100 K | 0 | 64 K | (0.1) | 12 K | (0.2) | (0.1) | (0.1) |
| Other Items | 49.0 | 0 | 0 | 25 K | 15 K | 0 | 0 | 0 | 29.7 | (36.6) | 2 K | 6 K |
| Cash From Investing Activities | 49.0 | 0 | 0 | 25 K | 85 K | 0 | 64 K | (0.1) | 29.7 | (36.8) | (0.1) | (0.1) |
| FINANCING CASH FLOW | ||||||||||||
| Common Stock Repurchased | 1 K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 0 | 0 | 0 | 0.8 | 25.9 | 4.4 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | (0.3) | (0.4) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 29 K | (0.2) | 0.8 | 25.5 | (0.4) | 0.9 | (2.2) | (0.3) | (4.4) | 0.2 | 0 | 2.4 |
| Cash From Financing Activities | 30 K | (0.2) | 98.0 | 74.0 | 14.8 | 15.9 | 47.8 | 25.6 | 16 K | 46.9 | 13.8 | 12.3 |
| CHANGE IN CASH | ||||||||||||
| Net Change In Cash | 5.1 | (49.4) | 62.8 | 48.2 | (12.4) | (9.5) | 24.9 | 0.4 | 10.1 | (8.1) | 3.7 | 4.6 |
| FREE CASH FLOW | ||||||||||||
| Free Cash Flow | (43.8) | (49.0) | (35.2) | (26.0) | (27.0) | (26.0) | (22.2) | (25.5) | (19.6) | (18.2) | (10.1) | (7.7) |